MELBOURNE, AUSTRALIA--(MARKET WIRE)--Sep 20, 2007 -- Prana Biotechnology Limited (NasdaqCM:PRAN - News) (ASX:PBT.AX - News), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced that Rudolph E. Tanzi, Ph.D., Co-Founding Scientist of Prana Biotechnology, together with other distinguished medical and scientific experts, will participate in a panel discussion at the Alzheimer's Association New York City Chapter's 20th Annual Meeting, at 6:00 p.m. on September 25, 2007.